CURIS, INC. Capital Expenditures Incurred but Not yet Paid
CURIS, INC. (CRIS) reported Capital Expenditures Incurred but Not yet Paid of $0 for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-03.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2021-08-03
- CURIS, INC. capital expenditures incurred but not yet paid for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- CURIS, INC. capital expenditures incurred but not yet paid for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- CURIS, INC. capital expenditures incurred but not yet paid for the quarter ending 2020-06-30 was $121.00K.
- CURIS, INC. capital expenditures incurred but not yet paid for the quarter ending 2020-03-31 was $26.00K.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month |
|---|---|---|
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $0.00 10-Q · filed 2021-08-03 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-12 | |
| 2020-06-30 | $121.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $147.00K 10-Q · filed 2021-08-03 |
| 2020-03-31 | $26.00K 10-Q · filed 2021-05-12 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $0.00 10-Q · filed 2020-08-04 |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-12 | |
| 2018-06-30 | $8.00K 10-Q · filed 2019-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |